Global Biomedical Sensors Market Expected to Reach $18.4 Billion by 2022

Estimated reading time: 1 minute

The global biomedical sensors market was valued at $12.96 billion in 2016 and is expected to reach a value of $18.44 billion by the end of 2022, growing at a projected CAGR of 6.05%.

Technological advancements in the field of biomedical sensors using microtechnology and nanotechnology will bring tiny, robust, smart and cost-effective sensors that are adaptable to the individual genetic formulation. These sensors can be set to trigger alerts when they enlist unpredictable readings, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. Investments in developing sensors with such capabilities will act as a major factor for the growth of the market and eventually these products will find huge demand in the healthcare industry.

Utility in the hazardous environments and geographical locations which are susceptible to natural disasters will drive the biomedical sensors market. Increased demand from the healthcare industry to monitor patients with diabetic and heart conditions will further boost the growth of the market. Early detection of irregularities in the health status of the patients along with necessary medical attention will contribute to the better quality of life.

Even though biomedical sensors are playing a major role in life-saving situations, the market faces certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption.